Inhalation nebulization treatment with let-7b significantly increases the anti-tumor function of CD8+TIL and reduces the expression of PD-L1 in lung cancer cells, showing remarkable tumor inhibitory effects with lower side effects [244]. The gene discussed is CD274; the disease is lung cancer.